We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Interim guidance and information on the law for healthcare professionals
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The Home Secretary has formally commissioned the Advisory Council on the Misuse of Drugs (ACMD) to conduct a longer-term review of cannabis-based products for medicinal use.
How to use an economic evaluation to evaluate your digital health product.
The therapeutic and medicinal benefits of cannabis-based products – a review of recent evidence.
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified.
How to use a cost utility analysis to evaluate your digital health product.
Report examining issues relating to road safety and the use and prescription of medical cannabis.
UK Government responds to expert committee recommendations on consumer CBD products.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
This factsheet outlines the domestic control measures that apply to cannabis, cannabidiol (CBD) and controlled cannabinoids.
In July 2007 the Home Secretary requested, in the light of “real public concern about the potential mental health effects of cannabis use, in…
Monitoring significant occupational exposures to HIV, hepatitis B and hepatitis C in healthcare workers, and advising on avoiding injuries.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).